Procedure/intervention/task | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | *Day 10 | *Day 30 | 3-month |
---|---|---|---|---|---|---|---|---|---|
Selection criteria1 | X | Â | Â | Â | Â | Â | Â | Â | Â |
Informed consent | X | Â | Â | Â | Â | Â | Â | Â | Â |
CT scan head2 | X | Â | Â | Â | Â | Â | Â | Â | Â |
HsTnT3 | X | Â | Â | Â | Â | Â | Â | Â | Â |
Vital signs4 | X | X | X | X | X | X | Â | Â | Â |
Randomization | X | Â | Â | Â | Â | Â | Â | Â | Â |
Treatment protocol5 | X | X | X | X | X | X | Â | Â | Â |
Electrocardiography (ECG) | X | X | Â | Â | Â | Â | Â | Â | Â |
Echocardiography6 | X | Â | Â | Â | Â | Â | Â | Â | Â |
Laboratory tests (S100B, enolase, cytokines (IL-1b,6,8,18)) | X | X | X | Â | Â | Â | Â | Â | Â |
Serum epinephrine | X | X | Â | Â | Â | Â | Â | Â | Â |
Routine blood tests7 | X | Â | Â | Â | Â | Â | Â | Â | Â |
Glasgow Outcome Score (GOS) | Â | Â | Â | Â | Â | Â | Â | Â | X |
Last day follow-up | Â | Â | Â | Â | Â | Â | Â | Â | X |